Search results
Ozempic Maker Novo Nordisk Stock Up More Than 31% In 2024, But Is It Too Late To Buy Shares?
Investor's Business Daily· 5 days agoThe company also announced in February it plans to buy drug manufacturer Catalent for $16.5 billion...
What Happened After I Stopped Taking a Weight-Loss Drug
The Wall Street Journal· 5 days agoFour months ago, I wrote about losing 40 pounds on Mounjaro and wondered how I would do without the ...
Ozempic and Wegovy Are Fueling Novo Nordisk's Business, but Something Else May Be an Even Bigger...
Motley Fool via Yahoo Finance· 3 days agoEarlier this year, the company bought drug subcontractor Catalent for $16.5 billion. The acquisition...
Dad, 48, recalls the subtle symptom he had for a year leading up to widow maker heart attack
TODAY via Yahoo News· 1 day agomaker, Nukta says. Risk factors include: Being a smoker Having high blood pressure Having high...
Feds plan for smoother access to RSV infant shot
Politico· 7 days agoA mix of private and public payers covers Canadians’ medications...legislation to maintain their hold on power. Johnson & Johnson struck a deal to buy an experimental skin ...
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Investor's Business Daily· 4 days agoEli Lilly (LLY), Novo Nordisk (NVO), Vertex Pharmaceuticals (VRTX), Intuitive Surgical (ISRG) and...
Healthcare Companies Release Supply Tracker for Diabetes, Weight Loss Medications
iTech Post· 6 days agoRo launched its GLP-1 Supply Tracker that will notify patients when a GLP-1 drug is back in the...
Aristocrats in Disguise: 3 Blue-Chip Stocks With Stealth Growth Potential Aristocrats in Disguise: 3...
InvestorPlace· 5 days agoAlthough there is no hard-and-fast rule about what constitutes a blue-chip stock, they all tend to...
Deadly 2023 heat wave in metro Phoenix didn’t discriminate in claiming victims of every kind
St. Louis Post-Dispatch· 2 days agoPriscilla Orr, 75, was living in her old white Kia in a supermarket parking lot last summer after...
